Serina Therapeutics, Inc.

Serina Therapeutics, Inc. financial statements

Serina Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 130K10-K
Net income−USD 19.18M10-K
Cash and equivalentsUSD 3.06M10-Q
Total debtUSD 196KEODHD

Serina Therapeutics, Inc. financials on 6ix · Serina Therapeutics, Inc. on 6ix